These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 11862382

  • 41. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y, Chamuleau ME, van de Loosdrecht AA, Tolosa E, Jorritsma T, Muris JJ, Dinnissen-van Poppel MJ, Snel SN, van de Corput L, Ossenkoppele GJ, Meijer CJ, Neefjes JJ, Marieke van Ham S.
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [Abstract] [Full Text] [Related]

  • 42. Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27.
    Feng XM, Liu N, Yang SG, Hu LY, Chen XL, Fang ZH, Ren Q, Lu SH, Liu B, Han ZC.
    Biochem Biophys Res Commun; 2008 Mar 14; 367(3):553-9. PubMed ID: 18178151
    [Abstract] [Full Text] [Related]

  • 43. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
    LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W.
    Nat Immunol; 2004 Sep 14; 5(9):899-908. PubMed ID: 15322541
    [Abstract] [Full Text] [Related]

  • 44. Transcriptional silencing of RFXAP in MHC class II-deficiency.
    van Eggermond MC, Tezcan I, Heemskerk MH, van den Elsen PJ.
    Mol Immunol; 2008 May 14; 45(10):2920-8. PubMed ID: 18336911
    [Abstract] [Full Text] [Related]

  • 45. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
    Peijnenburg A, Van Eggermond MJ, Gobin SJ, Van den Berg R, Godthelp BC, Vossen JM, Van den Elsen PJ.
    J Immunol; 1999 Jul 15; 163(2):794-801. PubMed ID: 10395672
    [Abstract] [Full Text] [Related]

  • 46. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
    El Hawary RE, Mauracher AA, Meshaal SS, Eldash A, Abd Elaziz DS, Alkady R, Lotfy S, Opitz L, Galal NM, Boutros JA, Pachlopnik Schmid J, Elmarsafy AM.
    J Allergy Clin Immunol Pract; 2019 Mar 15; 7(3):856-863. PubMed ID: 30170160
    [Abstract] [Full Text] [Related]

  • 47. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM, Peijnenburg A, Gobin SJ, Boss JM, van den elsen PJ.
    J Immunol; 2000 Apr 01; 164(7):3666-74. PubMed ID: 10725724
    [Abstract] [Full Text] [Related]

  • 48. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A.
    Bontron S, Steimle V, Ucla C, Eibl MM, Mach B.
    Hum Genet; 1997 Apr 01; 99(4):541-6. PubMed ID: 9099848
    [Abstract] [Full Text] [Related]

  • 49. Defective class II transactivator expression in a B lymphoma cell line.
    Prod'homme T, Drénou B, De Ruyffelaere C, Barbieri G, Wiszniewski W, Bastard C, Charron D, Alcaide-Loridan C.
    Leukemia; 2004 Apr 01; 18(4):832-40. PubMed ID: 14973505
    [Abstract] [Full Text] [Related]

  • 50. MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.
    Naves R, Lennon AM, Barbieri G, Reyes L, Puga G, Salas L, Deffrennes V, Rosemblatt M, Fellous M, Charron D, Alcaïde-Loridan C, Bono MR.
    Int Immunol; 2002 May 01; 14(5):481-91. PubMed ID: 11978778
    [Abstract] [Full Text] [Related]

  • 51. [Research progress on regulation of class II MHC expression].
    Sun QH, Peng JP.
    Sheng Li Ke Xue Jin Zhan; 2004 Jan 01; 35(1):25-9. PubMed ID: 15127593
    [Abstract] [Full Text] [Related]

  • 52. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
    Anderson RA, Bryson GM, Parks JS.
    Mol Genet Metab; 1999 Nov 01; 68(3):333-45. PubMed ID: 10562460
    [Abstract] [Full Text] [Related]

  • 53. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
    Scholl T, Mahanta SK, Strominger JL.
    Proc Natl Acad Sci U S A; 1997 Jun 10; 94(12):6330-4. PubMed ID: 9177217
    [Abstract] [Full Text] [Related]

  • 54. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.
    Zhou H, Glimcher LH.
    Immunity; 1995 May 10; 2(5):545-53. PubMed ID: 7749985
    [Abstract] [Full Text] [Related]

  • 55. K-562 cells lack MHC class II expression due to an alternatively spliced CIITA transcript with a truncated coding region.
    Day NE, Ugai H, Yokoyama KK, Ichiki AT.
    Leuk Res; 2003 Nov 10; 27(11):1027-38. PubMed ID: 12859996
    [Abstract] [Full Text] [Related]

  • 56. Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients.
    Warren DS, Wolfe BD, Gould SJ.
    Hum Mutat; 2000 Nov 10; 15(6):509-21. PubMed ID: 10862081
    [Abstract] [Full Text] [Related]

  • 57. Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome.
    Nekrep N, Geyer M, Jabrane-Ferrat N, Peterlin BM.
    Mol Cell Biol; 2001 Aug 10; 21(16):5566-76. PubMed ID: 11463838
    [Abstract] [Full Text] [Related]

  • 58. Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.
    Wiszniewski W, Fondaneche MC, Lambert N, Masternak K, Picard C, Notarangelo L, Schwartz K, Bal J, Reith W, Alcaide C, de Saint Basile G, Fischer A, Lisowska-Grospierre B.
    Immunogenetics; 2000 Apr 10; 51(4-5):261-7. PubMed ID: 10803838
    [Abstract] [Full Text] [Related]

  • 59. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.
    Peijnenburg A, Van den Berg R, Van Eggermond MJ, Sanal O, Vossen JM, Lennon AM, Alcaïde-Loridan C, Van den Elsen PJ.
    Immunogenetics; 2000 Jan 10; 51(1):42-9. PubMed ID: 10663561
    [Abstract] [Full Text] [Related]

  • 60. MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter Cohort.
    Gulec Koksal Z, Bilgic Eltan S, Topyildiz E, Sezer A, Keles S, Celebi Celik F, Ozhan Kont A, Gemici Karaaslan B, Sefer AP, Karali Z, Arik E, Ozek Yucel E, Akcal O, Karakurt LT, Yorgun Altunbas M, Yalcin K, Uygun V, Ozek G, Babayeva R, Aydogmus C, Ozcan D, Cavkaytar O, Keskin O, Kilic SS, Kiykim A, Arikoglu T, Genel F, Gulez N, Guner SN, Karaca NE, Reisli I, Kutukculer N, Altintas DU, Ozen A, Karakoc Aydiner E, Baris S.
    J Allergy Clin Immunol Pract; 2024 Sep 10; 12(9):2490-2502.e6. PubMed ID: 38996837
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.